PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65421-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65421-6/fulltext
Title :
PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65421-6&doi=10.1016/S1098-3015(10)65421-6
First page :
Section Title :
Open access? :
No
Section Order :
580